Literature DB >> 8707247

The metabolic organization of the adult human liver: a comparative study of normal, fibrotic, and cirrhotic liver tissue.

L Racine-Samson1, J Y Scoazec, A D'Errico, M Fiorentino, L Christa, A Moreau, C Roda, W F Grigioni, G Feldman.   

Abstract

Little is known about the alterations of metabolic organization of the human liver tissue in chronic liver diseases. We therefore compared the distribution of the following zonal metabolic markers in 10 samples of normal liver tissue, 10 samples of fibrotic tissue, and 22 samples of cirrhotic tissue: (a) the enzymatic activities of glucose-6-phosphatase (G6P), lactate dehydrogenase (LDH), succinate dehydrogenase (SDH), nicotinamide-adenine-dinucleotide-phosphate [NAPH] dehydrogenase (ND), beta-hydroxybutyrate dehydrogenase (HBDH), and glutamate dehydrogenase (GDH); (b) the protein glutamine synthetase (GLS); and (c) albumin messenger RNA (mRNA). The normal human hepatic lobule was characterized by the periportal predominance of G6P and SDH enzymatic activities and albumin mRNAs, the perivenous predominance of ND and GDH, the restriction of GLS to a small perivenous compartment, and the predominanc of beta-HBDH at the contact of both portal tracts and centrilobular veins. In fibrosis, the overall metabolic organization of the normal liver tissue was retained. The expression of periportal markers predominated around enlarged portal tracts and that of perivenous markers around residual centrilobular veins. GLS was constantly detected at the contact of centrilobular veins. In cirrhotic nodules, no zonation was observed for most enzymatic activities or for albumin. Only G6P usually predominated at the periphery of the nodules. GLS was constantly undetectable. No difference accordingly to the etiology of the underlying disease was observed. In conclusion, the normal human hepatic lobule presents a marked metabolic zonation, preserved in fibrotic lesions, but lost in cirrhotic nodules. The alterations of the metabolic organization observed in cirrhosis might contribute to the pathogenesis of some of the metabolic disorders associated with advanced liver disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707247     DOI: 10.1002/hep.510240118

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.

Authors:  Mitchell R McGill; Matthew R Sharpe; C David Williams; Mohammad Taha; Steven C Curry; Hartmut Jaeschke
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Proximal tubule glutamine synthetase expression is necessary for the normal response to dietary protein restriction.

Authors:  Hyun-Wook Lee; Gunars Osis; Mary E Handlogten; Jill W Verlander; I David Weiner
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-22

Review 3.  Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems.

Authors:  Alejandro Soto-Gutierrez; Albert Gough; Lawrence A Vernetti; D L Taylor; Satdarshan P Monga
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-03

Review 4.  Regulation of hepatocyte identity and quiescence.

Authors:  Carmen Berasain; Matías A Avila
Journal:  Cell Mol Life Sci       Date:  2015-06-19       Impact factor: 9.261

5.  Differential hepatocellular zonation pattern of cholesterol 7alpha-hydroxylase (Cyp7a1) and sterol 12alpha-hydroxylase (Cyp8b1) in the mouse.

Authors:  Jin Wang; Maria Olin; Björn Rozell; Ingemar Björkhem; Curt Einarsson; Gösta Eggertsen; Mats Gåfvels
Journal:  Histochem Cell Biol       Date:  2007-01-20       Impact factor: 4.304

6.  De novo expression of glutamine synthetase during transformation of hepatic stellate cells into myofibroblast-like cells.

Authors:  J G Bode; T Peters-Regehr; A M Gressner; D Häussinger
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

Review 7.  Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Expert Rev Mol Diagn       Date:  2018-08-13       Impact factor: 5.225

Review 8.  Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity.

Authors:  David S Umbaugh; Hartmut Jaeschke
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2020-12-09       Impact factor: 3.869

9.  Therapeutic effects of hepatocyte growth factor-overexpressing dental pulp stem cells on liver cirrhosis in a rat model.

Authors:  Xiao-Fang Cao; Shi-Zhu Jin; Liang Sun; Yuan-Bo Zhan; Feng Lin; Ying Li; Ying-Lian Zhou; Xiu-Mei Wang; Li Gao; Bin Zhang
Journal:  Sci Rep       Date:  2017-11-17       Impact factor: 4.379

10.  Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control.

Authors:  Mario Brosch; Kathrin Kattler; Alexander Herrmann; Witigo von Schönfels; Karl Nordström; Daniel Seehofer; Georg Damm; Thomas Becker; Sebastian Zeissig; Sophie Nehring; Fabian Reichel; Vincent Moser; Raghavan Veera Thangapandi; Felix Stickel; Gustavo Baretton; Christoph Röcken; Michael Muders; Madlen Matz-Soja; Michael Krawczak; Gilles Gasparoni; Hella Hartmann; Andreas Dahl; Clemens Schafmayer; Jörn Walter; Jochen Hampe
Journal:  Nat Commun       Date:  2018-10-08       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.